Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals

Bibliographic Details
Main Author: Andrade, Denise de
Publication Date: 2009
Other Authors: Souza, Paula Regina de, Beraldo, Carolina Contador, Watanabe, Evandro, Lima, Mery Elen, Haas, Vanderlei José
Format: Article
Language: eng
Source: Brazilian Journal of Pharmaceutical Sciences
Download full: https://www.revistas.usp.br/bjps/article/view/10712
Summary: The use of mouthwashes in critical patients has been a source of concern for health professionals due to the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium chloride solution presented better results in comparison to other products, that is, 39 (97.5%) strains from hospital patients with MID 1:128, and 37 (92.5%) of individuals from the community had MID 1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the worst MID results, 65% of the strains from individuals from the community and 10% of hospital strains were not inhibited at a dilution of 1:2.
id USP-31_e4bd42a47f25012610b9133915a4aeb9
oai_identifier_str oai:revistas.usp.br:article/10712
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals Saúde bucalStaphylococcus sppAntissépticos bucaisHigiene bucalOral healthStaphylococcus sppMouthwashesOral hygiene The use of mouthwashes in critical patients has been a source of concern for health professionals due to the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium chloride solution presented better results in comparison to other products, that is, 39 (97.5%) strains from hospital patients with MID 1:128, and 37 (92.5%) of individuals from the community had MID 1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the worst MID results, 65% of the strains from individuals from the community and 10% of hospital strains were not inhibited at a dilution of 1:2. O uso de antissépticos bucais tem sido uma das preocupações dos profissionais de saúde considerando a diversidade de produtos, o que traz a insegurança sobre qual é o mais adequado. Objetivou-se avaliar a suscetibilidade de Staphylococcus spp. isolado da saliva de indivíduos adultos da comunidade e do hospital frente a antissépticos bucais. Os antissépticos avaliados foram: solução de Cloreto de Cetilpiridínio, Listerine® e Neen®. Na coleta de saliva para o isolamento do Staphylococcus spp. utilizou-se o swab de alginato de cálcio. O processamento microbiológico envolveu o crescimento, isolamento, identificação das cepas, determinação da DIM. Foi considerada DIM a maior diluição que inibiu completamente as cepas. A eficácia dos produtos foi avaliada por meio da análise de variância (ANOVA) bilateral com medidas repetidas, e pelo método de ajuste de Bonferroni nas comparações múltiplas, com um nível de significância α=0,05. Totalizou-se 80 cepas de Staphylococcus spp. sendo 40 isoladas de pacientes da UTI e 40 de indivíduos da comunidade. Comparando os resultados é possível verificar que a solução de cloreto de cetilpiridínio apresentou melhores resultados em relação aos demais produtos, ou seja, 39 (97,5%) das cepas hospitalares DIM 1:128 e da comunidade 37 (92,5%) DIM 1:64. Para Neen® nos dois grupos a DIM foi de 1:2 e 1:4. Listerine® apresentou o pior resultado em termos da DIM, sendo que 65% das cepas da comunidade e 10% hospitalar não foram inibidas na diluição 1:2. Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2009-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/1071210.1590/S1984-82502009000300021Brazilian Journal of Pharmaceutical Sciences; Vol. 45 No. 3 (2009); 551-557 Brazilian Journal of Pharmaceutical Sciences; v. 45 n. 3 (2009); 551-557 Brazilian Journal of Pharmaceutical Sciences; Vol. 45 Núm. 3 (2009); 551-557 2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/10712/12480Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessAndrade, Denise deSouza, Paula Regina deBeraldo, Carolina ContadorWatanabe, EvandroLima, Mery ElenHaas, Vanderlei José2012-05-12T16:02:09Zoai:revistas.usp.br:article/10712Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2012-05-12T16:02:09Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
title Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
spellingShingle Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
Andrade, Denise de
Saúde bucal
Staphylococcus spp
Antissépticos bucais
Higiene bucal
Oral health
Staphylococcus spp
Mouthwashes
Oral hygiene
title_short Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
title_full Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
title_fullStr Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
title_full_unstemmed Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
title_sort Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals
author Andrade, Denise de
author_facet Andrade, Denise de
Souza, Paula Regina de
Beraldo, Carolina Contador
Watanabe, Evandro
Lima, Mery Elen
Haas, Vanderlei José
author_role author
author2 Souza, Paula Regina de
Beraldo, Carolina Contador
Watanabe, Evandro
Lima, Mery Elen
Haas, Vanderlei José
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Andrade, Denise de
Souza, Paula Regina de
Beraldo, Carolina Contador
Watanabe, Evandro
Lima, Mery Elen
Haas, Vanderlei José
dc.subject.por.fl_str_mv Saúde bucal
Staphylococcus spp
Antissépticos bucais
Higiene bucal
Oral health
Staphylococcus spp
Mouthwashes
Oral hygiene
topic Saúde bucal
Staphylococcus spp
Antissépticos bucais
Higiene bucal
Oral health
Staphylococcus spp
Mouthwashes
Oral hygiene
description The use of mouthwashes in critical patients has been a source of concern for health professionals due to the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium chloride solution presented better results in comparison to other products, that is, 39 (97.5%) strains from hospital patients with MID 1:128, and 37 (92.5%) of individuals from the community had MID 1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the worst MID results, 65% of the strains from individuals from the community and 10% of hospital strains were not inhibited at a dilution of 1:2.
publishDate 2009
dc.date.none.fl_str_mv 2009-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10712
10.1590/S1984-82502009000300021
url https://www.revistas.usp.br/bjps/article/view/10712
identifier_str_mv 10.1590/S1984-82502009000300021
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10712/12480
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 45 No. 3 (2009); 551-557
Brazilian Journal of Pharmaceutical Sciences; v. 45 n. 3 (2009); 551-557
Brazilian Journal of Pharmaceutical Sciences; Vol. 45 Núm. 3 (2009); 551-557
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1787713366408560640